BR9811861A - Polipeptìdeos de fatores de crescimento ligantes de heparina (fclh) - Google Patents
Polipeptìdeos de fatores de crescimento ligantes de heparina (fclh)Info
- Publication number
- BR9811861A BR9811861A BR9811861-7A BR9811861A BR9811861A BR 9811861 A BR9811861 A BR 9811861A BR 9811861 A BR9811861 A BR 9811861A BR 9811861 A BR9811861 A BR 9811861A
- Authority
- BR
- Brazil
- Prior art keywords
- fclh
- heparin
- polypeptides
- binding growth
- growth factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Abstract
Patente de Invenção: <B>"POLIPEPTìDEOS DE FATORES DE CRESCIMENTO LIGANTES DE HEPARINA (FCLH)"<D>. Polipeptídeos de fatores de crescimento ligantes de heparina substancialmente puros (FsCLH), ácido nucléicos codificadores dos FsCLH e anticorpos que se ligam aos FsCLH da invenção são fornecidos. Os polipeptídeos do FCLH são úteis nos métodos para a indução de formação de osso, cartilagem e tecidos, para o crescimento e desenvolvimento do endométrio e na aceleração da cicatrização de ferimentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/908,526 US5876730A (en) | 1997-08-07 | 1997-08-07 | Heparin-binding growth factor (HBGF) polypeptides |
PCT/US1998/016423 WO1999007407A1 (en) | 1997-08-07 | 1998-08-06 | Heparin-binding growth factor (hbgf) polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9811861A true BR9811861A (pt) | 2000-08-15 |
Family
ID=25425931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9811861-7A BR9811861A (pt) | 1997-08-07 | 1998-08-06 | Polipeptìdeos de fatores de crescimento ligantes de heparina (fclh) |
Country Status (15)
Country | Link |
---|---|
US (3) | US5876730A (pt) |
EP (1) | EP1003545B1 (pt) |
JP (2) | JP4638027B2 (pt) |
CN (1) | CN1276729A (pt) |
AT (1) | ATE395927T1 (pt) |
AU (1) | AU744585B2 (pt) |
BR (1) | BR9811861A (pt) |
CA (1) | CA2299411A1 (pt) |
DE (1) | DE69839516D1 (pt) |
DK (1) | DK1003545T3 (pt) |
ES (1) | ES2307322T3 (pt) |
IL (1) | IL134330A0 (pt) |
NO (1) | NO20000579L (pt) |
PT (1) | PT1003545E (pt) |
WO (1) | WO1999007407A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033878A1 (fr) | 1997-12-25 | 1999-07-08 | Japan Tobacco Inc. | Anticorps monoclonal contre le facteur de croissance du tissu conjonctif et ses mises en applications medicales |
CA2346406C (en) * | 1998-10-06 | 2009-02-17 | Anton Wellstein | Detection of pleiotrophin |
US7141384B1 (en) | 1998-10-06 | 2006-11-28 | Georgetown University | Detection of pleiotrophin |
WO2000035936A1 (en) * | 1998-12-14 | 2000-06-22 | University Of Miami | Connective tissue growth factor fragments and methods and uses thereof |
US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
AU2001288392A1 (en) | 2000-08-30 | 2002-03-13 | University Of Delaware | Delivery system for heparin-binding growth factors |
US7297343B2 (en) * | 2001-07-31 | 2007-11-20 | Biosurface Engineering Technologies, Inc. | Bioactive medical films |
FR2828104B1 (fr) * | 2001-08-01 | 2005-06-24 | Chu Montpellier | Utilisation d'inhibiteurs du facteur de croissance epidermique liant l'heparine ou d'inhibiteurs de ses recepteurs pour la preparation de medicaments utiles pour traiter le myelome |
WO2003024308A2 (en) | 2001-09-18 | 2003-03-27 | Fibrogen, Inc. | Methods of assaying connective tissue growth factor |
US6965025B2 (en) * | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
GB0225197D0 (en) * | 2002-10-30 | 2002-12-11 | Univ Sheffield | Surface |
US7405274B2 (en) | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
US20050153395A1 (en) * | 2003-09-29 | 2005-07-14 | Children's Hospital Inc. | Unique integrin binding site in connective tissue growth factor (CTGF) |
CN101884789A (zh) | 2004-02-11 | 2010-11-17 | 法布罗根股份有限公司 | Ctgf作为糖尿病肾病的治疗靶点 |
EP1742965B1 (en) | 2004-04-28 | 2012-10-24 | Fibrogen, Inc. | Treatments for pancreatic cancer |
DE102004021872B3 (de) | 2004-05-04 | 2005-12-22 | Infineon Technologies Ag | Chipkarte, Verfahren zum Herstellen einer Chipkarte und elektrisch leitfähiges Kontaktierungselement |
US20070049739A1 (en) * | 2005-08-30 | 2007-03-01 | Biomet Manufacturing Corp. | Method and system for extracting blood-derived growth factors |
US8946172B2 (en) * | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
CN103429270B (zh) | 2008-08-25 | 2016-11-23 | 埃克斯雷德制药有限公司 | 阻止结缔组织生长因子的反义核苷酸及其用途 |
CN101497656B (zh) * | 2009-03-09 | 2012-08-15 | 东南大学 | 与整合素αvβ3具有高结合活性的多肽及其应用 |
WO2011002525A1 (en) | 2009-07-02 | 2011-01-06 | Fibrogen, Inc. | Methods for treatment of muscular dystrophy |
US9102721B2 (en) | 2011-01-21 | 2015-08-11 | Fibrogen, Inc. | Therapeutic method |
CA2825059A1 (en) | 2011-02-02 | 2012-08-09 | Excaliard Pharmaceuticals, Inc. | Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5235042A (en) | 1984-02-29 | 1993-08-10 | The Children's Medical Center Corporation | Endothelial cell growth factor |
US4868113A (en) * | 1986-03-03 | 1989-09-19 | Rorer Biotechnology, Inc. | Recombinant DNA vector encoding human endothelial cell growth factor |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
IL85018A0 (en) * | 1988-01-03 | 1988-06-30 | Orgenics Ltd | Stable chromogenic substrate mixture of indoxyl phosphate and tetrazolium salt,method of making and using same in biological and diagnostic assays |
US5225326A (en) * | 1988-08-31 | 1993-07-06 | Research Development Foundation | One step in situ hybridization assay |
ATE199095T1 (de) | 1990-10-16 | 2001-02-15 | Childrens Medical Center | Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf) |
US5408040A (en) * | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5565332A (en) * | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5596090A (en) * | 1992-07-24 | 1997-01-21 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human VCAM-1 RNA |
EP1217067A2 (en) | 1994-07-12 | 2002-06-26 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
US5646115A (en) * | 1994-10-07 | 1997-07-08 | Heska Corporation | Ectoparasite saliva proteins and apparatus to collect such proteins |
US5607918A (en) | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
US5789389A (en) * | 1995-03-17 | 1998-08-04 | Board Of Trustees Of University Of Illinois | BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs |
US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
-
1997
- 1997-08-07 US US08/908,526 patent/US5876730A/en not_active Expired - Lifetime
-
1998
- 1998-07-09 US US09/113,924 patent/US7897732B2/en not_active Expired - Fee Related
- 1998-08-06 IL IL13433098A patent/IL134330A0/xx unknown
- 1998-08-06 JP JP2000506996A patent/JP4638027B2/ja not_active Expired - Lifetime
- 1998-08-06 EP EP98938435A patent/EP1003545B1/en not_active Expired - Lifetime
- 1998-08-06 CN CN98809911A patent/CN1276729A/zh active Pending
- 1998-08-06 AT AT98938435T patent/ATE395927T1/de active
- 1998-08-06 CA CA002299411A patent/CA2299411A1/en not_active Abandoned
- 1998-08-06 PT PT98938435T patent/PT1003545E/pt unknown
- 1998-08-06 BR BR9811861-7A patent/BR9811861A/pt not_active IP Right Cessation
- 1998-08-06 DE DE69839516T patent/DE69839516D1/de not_active Expired - Lifetime
- 1998-08-06 DK DK98938435T patent/DK1003545T3/da active
- 1998-08-06 AU AU86962/98A patent/AU744585B2/en not_active Ceased
- 1998-08-06 ES ES98938435T patent/ES2307322T3/es not_active Expired - Lifetime
- 1998-08-06 WO PCT/US1998/016423 patent/WO1999007407A1/en active IP Right Grant
-
2000
- 2000-02-04 NO NO20000579A patent/NO20000579L/no not_active Application Discontinuation
-
2009
- 2009-06-17 JP JP2009144424A patent/JP2009254370A/ja active Pending
-
2011
- 2011-02-28 US US13/037,219 patent/US20110160445A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20010007019A1 (en) | 2001-07-05 |
JP4638027B2 (ja) | 2011-02-23 |
CA2299411A1 (en) | 1999-02-18 |
EP1003545A1 (en) | 2000-05-31 |
AU744585B2 (en) | 2002-02-28 |
US5876730A (en) | 1999-03-02 |
WO1999007407A1 (en) | 1999-02-18 |
NO20000579L (no) | 2000-02-25 |
CN1276729A (zh) | 2000-12-13 |
JP2009254370A (ja) | 2009-11-05 |
EP1003545A4 (en) | 2002-03-06 |
EP1003545B1 (en) | 2008-05-21 |
AU8696298A (en) | 1999-03-01 |
NO20000579D0 (no) | 2000-02-04 |
DK1003545T3 (da) | 2008-08-25 |
ES2307322T3 (es) | 2008-11-16 |
JP2001513334A (ja) | 2001-09-04 |
ATE395927T1 (de) | 2008-06-15 |
WO1999007407A9 (en) | 1999-05-06 |
PT1003545E (pt) | 2008-08-13 |
IL134330A0 (en) | 2001-04-30 |
DE69839516D1 (de) | 2008-07-03 |
US7897732B2 (en) | 2011-03-01 |
US20110160445A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9811861A (pt) | Polipeptìdeos de fatores de crescimento ligantes de heparina (fclh) | |
EE9900611A (et) | Osteoprotegeriini siduvad valgud ja retseptorid | |
DE59708957D1 (de) | Chirurgisches instrument zum mechanischen entfernen von knochenzement | |
BR9813028A (pt) | Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos | |
DE69500014T2 (de) | Widerlager zur Klammerung von weichem Gewebe | |
DK0648838T3 (da) | Vævsinhibitor af metalloproteinase type tre (TIMP-3) | |
DE69837924D1 (de) | Chromophoren zur herstellung von neuen tandem-konjugaten | |
DE68903846D1 (de) | Neue galenische form von fenofibrat. | |
DE69829858D1 (de) | System zum verankern von gewebe an knochen | |
CY1106260T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων | |
PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
BR9609424A (pt) | Novos peptìdeos, compostos, composição farmacêutica, processo para tratar um tumor em um mamìfero, e, processo para preparar os compostos | |
BR9811948A (pt) | Secretores de hormÈnio do crescimento | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
DE69010294T2 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
BR0114977A (pt) | segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos | |
ES2164169T3 (es) | Proteinas estimulantes de celulas t de pestivirus. | |
DE29713569U1 (de) | Trokar zur Einführung von chirurgischen Instrumenten | |
BR9712767A (pt) | Expressão especìfica para tecido de proteìna de retinoblastoma | |
DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
ATE254469T1 (de) | Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten | |
BR0113623A (pt) | Proteìnas sintéticas de estìmulo da eritropoiese | |
BRPI9809078B8 (pt) | peptídeo sintético utilizáveis nos testes biológicos para a detecção das infecções devido aos vírus hiv1 do grupo o, composição que os compreende, processo de imunodosagem in vitro e kit de diagnóstico. | |
IS5210A (is) | Notkun á fáliðupróteini brjóskundirstöðuefnis viðmeðhöndlun á liðagigt | |
DE29820434U1 (de) | System zum Fixieren von Knochenfrakturen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A,7AE 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007. |